ROCHESTER, N.Y., March 28 /PRNewswire/ -- The National Science Foundation awarded a Small Business Innovation Research (SBIR) grant to Integrated Nano- Technologies (INT) for further research and development of its novel DNA detection technology. The BioDetect(TM) technology platform and portable system, which integrates DNA and microelectronics, accurately detects the presence of biological agents, such as SARS, anthrax and smallpox, in as little as 20 minutes. The two-year grant is for $500,000. "It is gratifying to receive this grant as it validates the value of INT's technology by a government agency, and accelerates our development program," said Mike Connolly, Ph.D., J.D., CEO and founder of INT. "The BioDetect System offers a solution to one of the greatest challenges in biosecurity -- the rapid and accurate detection of biological agents in the field, not in a laboratory." About INT's Technology Integrated Nano-Technologies' core technology is a unique integration of molecular biology, chemistry and microelectronics that facilitates the development of technically advanced detection systems and other devices. Biological agent identification is based on the ability of DNA probes on a microchip to attract and bind to specific sequences in the DNA of a target organism. DNA is extracted from a sample and passed over a sensor, where it attaches to the organism-specific probes. The attached strands are metalized through a chemical process, producing a strong electrical signal for computer analysis. The BioDetect platform consists of an electronic analyzer and single-use, disposable test cards. Unlike other detection systems, BioDetect(TM) technology does not depend on polymerase chain reaction (PCR), and consequently does not share PCR's problems with speed, stability and sensitivity. About the National Science Foundation The National Science Foundation, an independent agency of the Federal Government, invites (by solicitation) eligible business concerns to participate in its programs. NSF supports high quality projects on important scientific, engineering, or science/engineering education problems and opportunities that could lead to significant commercial and public benefit if the research is successful. About Integrated Nano-Technologies, LLC Rochester, NY-based Integrated Nano-Technologies, LLC is a leading innovator in highly accurate, sensitive, rapid, portable, electronic, biological agent identification technology. Built around the BioDetect(TM) platform, INT's devices are highly portable and use disposable test cards to test field samples for numerous biological agents, including anthrax, in as little as 20 minutes. Future developments of the platform will enable the medical community to identify specific illness-causing pathogens in patients without sending samples to laboratories, facilitating faster and more accurate treatment. For more information about Integrated Nano-Technologies, call 585- 334-0170 or visit INT's Web site at http://www.integratednano.com. This press release contains forward-looking statements that are based upon our current expectations and speak only as of the date hereof. Our actual results may differ materially and adversely from those expressed in any forward-looking statements as a result of various factors and uncertainties, including our ability to successfully develop products, rapid technological change in our markets, changes in demand for our future products, legislative, regulatory and competitive developments and general economic conditions. We undertake no obligation to revise or update publicly any forward-looking statements for any reason.
SOURCE Integrated Nano-Technologies, LLC